Boston Scientific Inc. (BSX): Today's Featured Health Services Laggard

Boston Scientific ( BSX) pushed the Health Services industry lower today making it today's featured Health Services laggard. The industry as a whole closed the day down 0.5%. By the end of trading, Boston Scientific fell $0.22 (-2.4%) to $9.15 on average volume. Throughout the day, 18,762,723 shares of Boston Scientific exchanged hands as compared to its average daily volume of 18,661,800 shares. The stock ranged in price between $9.15-$9.36 after having opened the day at $9.32 as compared to the previous trading day's close of $9.37. Other companies within the Health Services industry that declined today were: Pingtan Marine Enterprise ( PME), down 65.1%, Intuitive Surgical ( ISRG), down 16.1%, Uroplasty ( UPI), down 9.9% and NeoGenomics ( NEO), down 7.0%.

Boston Scientific Corporation develops, manufactures, and markets medical devices used in various interventional medical specialties worldwide. Boston Scientific has a market cap of $12.5 billion and is part of the health care sector. Shares are up 63.5% year to date as of the close of trading on Monday. Currently there are 5 analysts that rate Boston Scientific a buy, no analysts rate it a sell, and 14 rate it a hold.

TheStreet Ratings rates Boston Scientific as a sell. The company's weaknesses can be seen in multiple areas, such as its deteriorating net income, disappointing return on equity, weak operating cash flow and feeble growth in its earnings per share.

On the positive front, China Cord Blood ( CO), up 9.4%, Health Management Associates ( HMA), up 8.3%, Addus Homecare Corporation ( ADUS), up 8.2% and Utah Medical Products ( UTMD), up 6.3% , were all gainers within the health services industry with Thermo Fisher Scientific ( TMO) being today's featured health services industry leader.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health services industry could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health services industry could consider ProShares Ultra Short Health Care ( RXD).

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

If you liked this article you might like

Baxter International, Becton Dickinson, Boston Scientific: Cramer's Top Takeaways

Perils of Politics: Cramer's 'Mad Money' Recap (Monday 7/31/17)

These Stocks Are Ready to Reverse Course

Modi's Visit to Meet Trump Focuses Big Spotlight on the H-1B Visa Debate

Cramer: These Sectors Look Bullish (Part III)